Delta HU is a potential marker to predict chemotherapy response for unresectable pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Delta HU is a potential marker to predict chemotherapy response for unresectable pancreatic ductal adenocarcinoma

Published:2021-06 Issue:4 Volume:21 Page:763-770
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

Zhou Yizhang,Gao Song,Zhou Bodong,Yuan Shuai,Ren He,Wang Yifei,Guo Xiaofan,Ren Jin,Chen Zhiqiang,Hao Jihui

Funder

Natural Science Foundation of Tianjin City

Taishan Scholar Project of Shandong Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference20 articles.

1. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma;Grossberg;Ca - Cancer J Clin,2020

2. Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future;Christenson;Lancet Oncol,2020

3. Potentially curable pancreatic adenocarcinoma: asco clinical practice guideline update;Khorana;J Clin Oncol,2019

4. Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic cancer;Kim;Pancreatology,2017

5. Prognostic predicting role of contrast-enhanced computed tomography for locally advanced pancreatic adenocarcinoma;Cheng;BioMed Res Int,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exposure to Intermittent Environmental Hypoxia Promotes Vascular Remodeling through Angiogenesis in the Liver of Largemouth Bass (Micropterus salmoides);Environmental Science & Technology;2023-02-21

2. Real-world dose reduction of standard and modified FOLFIRINOX in metastatic pancreatic cancer: a systematic review, evidence-mapping, and meta-analysis;Therapeutic Advances in Medical Oncology;2023-01

3. Ex‐vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy;DEN Open;2022-07-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3